Repurposing soluble guanylate cyclase stimulators from one to another isoform within the ROCG signalling module-Reference-Cited by-同舟云学术

Repurposing soluble guanylate cyclase stimulators from one to another isoform within the ROCG signalling module

Published:2022-08-29 Issue: Volume: Page:
ISSN:
Container-title:Repurposing soluble guanylate cyclase stimulators from one to another isoform within the ROCG signalling module
language:
Short-container-title:

Author:

Petraina Alexandra¹,Elbatreek Mahmoud H²,Elgert Christin³,Casas Ana I⁴,Neullens Christopher¹,Saridaki Theodora¹,Dao Vu Thao-vi⁵,Nogales Cristian¹,Mucke Hermann⁶,Behrends Sönke³,Schmidt Harald HHW¹

Affiliation:

1. Department of Pharmacology and Personalized Medicine, MeHNS, Faculty of Health, Medicine and Life Science, Maastricht University, Maastricht, 6229 ER, the Netherlands.

2. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt.

3. Department of Pharmacology, Toxicology and Clinical Pharmacy, University of Braunschweig, Germany

4. Department of Neurology and Center for Translational Neuro- and Behavioural Sciences (C-TNBS), University Clinic Essen, Essen, Germany.

5. Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt, Germany

6. H.M. Pharma Consultancy, Enenkelstrasse 28/32, A-1160, Vienna, Austria

Publisher

ScienceOpen

Reference5 articles.

1. A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct neuroprotection;Langhauser;npj Systems Biology and Applications,2018

2. From single drug targets to synergistic network pharmacology in ischemic stroke;Casas;Proceedings of the National Academy of Sciences,2019

3. Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology;Petraina;Cardiovascular Research,2022

4. Thiouracil Antithyroid Drugs as a New Class of Neuronal Nitric Oxide Synthase Inhibitors;Palumbo;Biochemical and Biophysical Research Communications,2001

5. NOX Inhibitors: From Bench to Naxibs to Bedside;Elbatreek,2020